Cargando…

P1543: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH HEMATOLOGICAL MALIGNANCIES THAT NEED VASOACTIVE SUPPORT – SINGLE CENTER STUDY

Detalles Bibliográficos
Autores principales:	Vitkon, Roy, Halak, Noa, Avivi, Irit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430127/ http://dx.doi.org/10.1097/01.HS9.0000973048.02697.ff

Ejemplares similares

P571: OUTPATIENT INITIATION OF VENETOCLAX-AZACITIDINE FOR SELECTED ACUTE MYELOID LEUKEMIA PATIENTS IS FEASIBLE AND SAFE: A REAL WORLD SINGLE CENTER ANALYSIS
por: Gat, Roi, et al.
Publicado: (2023)

P560: IMPROVEMENT IN OVERALL AND RELAPSE FREE SURVIVAL OF AML PATIENTS OVER THE AGE OF 75 SINCE THE APPROVAL OF VENETOCLAX IN A REAL-WORLD SINGLE CENTER STUDY.
por: Moshe, Yakir, et al.
Publicado: (2023)

P1543: MITAPIVAT DECREASES THE NEED FOR TRANSFUSIONS SECONDARY TO POORLY TOLERATED ANEMIA AND ACUTE EVENTS COMPARED TO PLACEBO IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY WHO ARE NOT REGULARLY TRANSFUSED
por: Al-Samkari, H., et al.
Publicado: (2022)

Predictors of Early and Late Mortality for Patients with Hematologic Malignancy and Invasive Mold Disease
por: Yashphe, Eva L., et al.
Publicado: (2021)

927. Clinical Characteristics and Outcomes of Norovirus Infection in Patients with Hematologic Malignancies: A Retrospective, Single Center Study
por: Brooks, Taylor, et al.
Publicado: (2021)

Historia de la ciencia, 1543-2001 /
por: Gribbin, John R.
Publicado: (2003)

The identity of the artists involved in Vesalius's Fabrica 1543.
por: Guerra, F
Publicado: (1969)

Daratumumab in combination with proteasome inhibitors, rapidly decreases polyclonal immunoglobulins and increases infection risk among relapsed multiple myeloma patients: a single center retrospective study
por: Vitkon, Roy, et al.
Publicado: (2021)

Vagal Nerve Activity Predicts Prognosis in Diffused Large B-Cell Lymphoma and Multiple Myeloma
por: Atar, Or, et al.
Publicado: (2023)

1543. Risk Reduction service delivery during the COVID Pandemic to a marginalized urban population in Newark, NJ
por: Rosmarin-DeStefano, Corey L, et al.
Publicado: (2020)

Zumárraga y la Inquisición mexicana, 1536-1543
por: Greenleaf, Richard E.
Publicado: (1988)

Extracorporeal Life Support in Patients with Hematologic Malignancies: A Single Center Experience
por: Choi, Kuk Bin, et al.
Publicado: (2016)

Giving Up the Gun. Japan's Reversion to the Sword, 1543-1879
por: Riker, Donald Kay
Publicado: (1981)

In Vitro Hematological and In Vivo Vasoactivity Assessment of Dextran Functionalized Graphene
por: Chowdhury, Sayan Mullick, et al.
Publicado: (2013)

P1569: HERPES ZOSTER VACCINATION IN HEMATOLOGY. A SINGLE CENTER EXPERIENCE.
por: Rodriguez, Natalia De Las Heras, et al.
Publicado: (2023)

1543. Elevated HIV Risk/Low Risk Perception in Rural Colorado
por: Rivera, Amanda, et al.
Publicado: (2023)

P1588: A SINGLE CENTER COMPARATIVE CLINICAL ANALYSIS OF THE SARS-COV-2 INFECTION BEFORE AND AFTER VACCINATION IN PATIENTS DIAGNOSED WITH HEMATOLOGIC MALIGNANCIES
por: Jiménez, M., et al.
Publicado: (2022)

Spanish explorers in the Southern United States, 1528- 1543 : the Narrative of Alvar Nuñez Cabeza de Vaca /
Publicado: (1925)

P1590: OUTCOME OF HYPERBARIC OXYGEN THERAPY IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES –A TERTIARY CANCER CENTER EXPERIENCE
por: Kim, K., et al.
Publicado: (2022)

Sepsis and neutropenia in hematological malignancies
por: Labiad, Y, et al.
Publicado: (2014)

P1723: A FEASIBILITY STUDY OF PEER SUPPORT IN FAMILY CAREGIVERS OF PATIENTS NEWLY DIAGNOSED WITH HEMATOLOGIC MALIGNANCY
por: Nielsen, I. H., et al.
Publicado: (2022)

1543. Ceftaroline Model-based Dose Individualization in an Infant with Kidney Disease and Mediastinitis
por: Murphy, Mark, et al.
Publicado: (2019)

Comparison of vasoactive medications and investigation determinants of mortality in children
por: Demirkol, D, et al.
Publicado: (2008)

Is admission of hematologic malignancies in the ICU justified?
por: Gasparovic, VG, et al.
Publicado: (2015)

Correlation between BNT162b2 mRNA Covid-19 vaccine-associated hypermetabolic lymphadenopathy and humoral immunity in patients with hematologic malignancy
por: Cohen, Dan, et al.
Publicado: (2021)

Unmet Supportive Care Needs of Patients with Hematological Malignancies: A Systematic Review
por: Tsatsou, Ioanna, et al.
Publicado: (2020)

Total inotrope exposure score: an extension of the vasoactive inotrope score
por: Bangalore, H, et al.
Publicado: (2015)

P966: SMOLDERING MULTIPLE MYELOMA (MM) PROGRESSING TO ACTIVE MM DURING FOLLOW-UP: REDUCED BONE DISEASE AND IMPROVED PROGRESSION-FREE AND OVERALL SURVIVAL COMPARED TO DE-NOVO NEWLY DIAGNOSED MM
por: Fridberg, Gil, et al.
Publicado: (2023)

1543 Counting the Costs of Falsely Labeling Patients as HIV-Positive in Tahoua Region, Niger
por: Megill, Matthew
Publicado: (2014)

Syphilis in Maria Salviati (1499–1543), Wife of Giovanni de’ Medici of the Black Bands
Publicado: (2020)

Syphilis in Maria Salviati (1499–1543), Wife of Giovanni de’ Medici of the Black Bands
por: Fornaciari, Antonio, et al.
Publicado: (2020)

Outcomes of patients with hematologic malignancies admitted to the ICU
por: Duayer, I, et al.
Publicado: (2015)

PIV-21 Respiratory viral infections in adult patients with hematologic malignancies
por: Bayram, A., et al.
Publicado: (2009)

P1745: ADHERENCE TO TREATMENT OF HEMATOLOGICAL MALIGNANCIES PATIENTS WITH ANXIETY AND DEPRESSION
por: Vybornykh, D. E., et al.
Publicado: (2022)

P1574: ANTINEOPLASTIC THERAPY FOR HEMATOLOGIC MALIGNANCIES DURING COVID-19
por: Chudnova, T., et al.
Publicado: (2022)

P1700: EARLY APPEARANCE OF CARDIOTOXICITY, IN CHILDREN WITH HEMATOLOGICAL MALIGNANCIES (HM)
por: Antoniadi, K., et al.
Publicado: (2022)

Remote Digital Microscopy Improves Hematology Laboratory Workflow by Reducing Peripheral Blood Smear Analysis Turnaround Time
por: Katz, Ben-Zion, et al.
Publicado: (2022)

Differential vasoactive effects of sildenafil and tadalafil on cerebral arteries –relevant to migraine?
por: Kruuse, Christina, et al.
Publicado: (2011)

Feasibly of CD24/CD11b as a Screening Test for Hematological Malignancies
por: Shapira, Shiran, et al.
Publicado: (2021)

Expression of aberrant antigens in hematological malignancies: A single center experience
por: Shahni, Aneeta, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_64fehgrf32oeq0vr7lvs63tcf0